Leuven, Belgium · Founded 2019 · Privately Held (backing)
Developer of therapeutic drugs designed to treat neuromuscular and neurodegenerative diseases. Augustine Therapeutics is based in Leuven, Belgium and was founded in 2019. Its last reported valuation was $73.5 million in Mar 2025. It has raised $93.4 million.
Last reported valuation
$73.5M
Oct 2026
Priced at
—
Total raised
$93.4M
Last round
—
Team — not yet on record
No current team members for Augustine Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Augustine Therapeutics with a free account
·The complete investor list: 14 names
·Watch Augustine Therapeutics: the Monday email on marks, rounds and moves
